Fairvalue-Calculator Fairvalue-Calculator
EN DE

Accuray Incorporated (ARAY) Fair Value & Analysis

Healthcare · US · Market cap $40.8M

Price$0.3301
Fair Value$0.6500
Upside+96.9%
Quality95/100
Evidence: Medium Range $0.2300 – $0.6500

Fair value as of: Jun 25, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Accuray Incorporated (ARAY) currently trades at $0.3301, while our model-based Fair Value estimate is $0.6500 — implying the stock looks roughly 96.9% undervalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium) — always confirm before acting.

About the company

Accuray Incorporated engages in the design, development, manufacture, and sale of radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China. The company offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate. It also provides the TomoTherapy platform, including the Radixact System, which allows for integrated radiation treatment planning, delivery, and data management, enabling clinicians to deliver ultra-precise treatments to approximately 50 patients per day; iDMS data management system, a fully integrated treatment planning and data management systems; and Accuray precision treatment planning system, a tre…

Open the full interactive analysis →

Similar stocks

Abbott Laboratories, (ABT) -95% Stryker Corporation (S1YK34) -45% Medtronic plc (MDT) -27% Boston Scientific Corporation (B1SX34) -11% Edwards Lifesciences Corporation (EW) -52% Siemens Healthineers AG (SEMHF) +11%

Frequently asked questions

Is Accuray Incorporated (ARAY) undervalued?
As of Jun 25, 2026, our model estimates a fair value of $0.6500 versus a price of $0.3301 — about +97% (undervalued). Model-based estimate, not financial advice.
What is the fair value of ARAY?
Our 21-model fair value for Accuray Incorporated is $0.6500 (as of Jun 25, 2026), built from audited fundamentals. The current price is $0.3301.
What is the quality score of ARAY?
Accuray Incorporated has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.